Earnings Call · Q3 FY2025·2025-11-04

Q3 25EPS -20.51%·Rev n/aQ2 25EPS -18.75%·Rev n/aQ1 25EPS +9.89%·Rev n/aQ4 24EPS -12.92%·Rev n/a⚠ consensus missing

Kymera Therapeutics, Inc. KYMR

Justine Koenigsberg — Vice President

Nello Mainolfi — Founder, President and CEO

Jared Gollob — Chief Medical Officer

Bruce Jacobs — Chief Financial Officer

+0.3%1d on move date+1.5% vs SPY3d+2.1%5d+2.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KYMR calls or request research access.

More KYMR calls Browse calls Request research access